Published in J Dtsch Dermatol Ges on September 01, 2003
[Reader's letter on Norbert Haas, Andrea Wulff-Woesten,W. Sterry and H. Meffert. The treatment of psoriasis capillitii with dithranol. JDDG 2003, 1:688-693]. J Dtsch Dermatol Ges (2003) 1.06
[Reader's letter on Norbert Haas, Andrea Wulff-Woesten, W. Steary and H. Meffert. The treatment of psoriasis capillitii with dithranol. JDDG 2003; 1:688-693]. J Dtsch Dermatol Ges (2003) 0.75
[Comment on the letter and response regarding "Treatment of psoriasis capilliti with Dethranol]. J Dtsch Dermatol Ges (2004) 0.75
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol (2006) 4.88
Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b. Dermatology (2002) 2.37
IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol (2007) 1.80
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) (2009) 1.76
Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res (2005) 1.65
Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol (2008) 1.59
Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm (2006) 1.56
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
Immunopathogenesis of psoriasis. Exp Dermatol (2007) 1.44
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.44
Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol (2006) 1.41
Clinical research in cutaneous T-cell lymphoma moving forward. Arch Dermatol (2008) 1.39
Virtual dermatohistopathology at http://www.pathowiki.org. J Dtsch Dermatol Ges (2012) 1.39
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma. J Immunother (2008) 1.35
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol (2006) 1.31
Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. J Clin Oncol (2010) 1.29
Porcine ear skin: an in vitro model for human skin. Skin Res Technol (2007) 1.28
Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol (2008) 1.26
S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges (2012) 1.25
Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer (2006) 1.21
Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging (2003) 1.20
The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur J Immunol (2009) 1.19
PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol (2007) 1.15
Variations of hair follicle size and distribution in different body sites. J Invest Dermatol (2004) 1.15
Biology of tumor necrosis factor-alpha- implications for psoriasis. Exp Dermatol (2004) 1.14
Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res (2006) 1.12
The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol (2007) 1.10
IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med (2013) 1.09
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08
One-year study on the variation of carotenoid antioxidant substances in living human skin: influence of dietary supplementation and stress factors. J Biomed Opt (2008) 1.08
Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg (2004) 1.07
Treatment of psoriasis with fumaric acid esters (Fumaderm). J Dtsch Dermatol Ges (2007) 1.05
Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One (2012) 1.04
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. J Immunother (2010) 1.04
Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol (2010) 1.04
Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res (2009) 1.04
Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol (2006) 1.04
Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging (2006) 1.03
Selective follicular targeting by modification of the particle sizes. J Control Release (2010) 1.03
Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm (2007) 1.01
Novel immunotherapies for psoriasis. Trends Immunol (2002) 1.01
Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol (2009) 1.01
Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncol Rep (2006) 1.00
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol (2008) 1.00
Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol (2005) 0.99
Follicular transport route--research progress and future perspectives. Eur J Pharm Biopharm (2008) 0.98
Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg (2004) 0.97
Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. J Exp Med (2011) 0.97
[S3-guidelines for the treatment of psoriasis vulgaris Update 2011]. J Dtsch Dermatol Ges (2011) 0.96
Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol (2006) 0.96
Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol (2006) 0.95
Apparent contradiction between negative effects of UV radiation and positive effects of sun exposure. Ger Med Sci (2005) 0.95
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results. Vaccine (2005) 0.94
Gender-related differences in the physiology of the stratum corneum. Dermatology (2005) 0.94
Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol (2005) 0.94
Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. J Invest Dermatol (2009) 0.93
Application of optical non-invasive methods in skin physiology: a comparison of laser scanning microscopy and optical coherent tomography with histological analysis. Skin Res Technol (2007) 0.93
In vivo skin treatment with tissue-tolerable plasma influences skin physiology and antioxidant profile in human stratum corneum. Exp Dermatol (2011) 0.93
Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm (2008) 0.92
Combined in vivo multiphoton and CARS imaging of healthy and disease-affected human skin. Microsc Res Tech (2011) 0.91
Water-filtered infrared-A (wIRA) can act as a penetration enhancer for topically applied substances. Ger Med Sci (2008) 0.91
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One (2010) 0.91
Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy. Melanoma Res (2006) 0.91
Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol (2010) 0.91
Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol (2011) 0.91
Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy (2004) 0.91
Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells. J Invest Dermatol (2007) 0.90
Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand. J Invest Dermatol (2011) 0.90
Persistent agmination of lymphomatoid papulosis: not a new entity, but localized lymphomatoid papulosis. J Am Acad Dermatol (2008) 0.90
Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch Dermatol Res (2005) 0.90
Nanoparticles in dermatology. Arch Dermatol Res (2011) 0.90
Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses. Dermatol Surg (2008) 0.89
Three decades of psoriasis research: where has it led us? Clin Dermatol (2007) 0.89
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition. Leuk Lymphoma (2012) 0.88
Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report. Cardiovasc Ultrasound (2005) 0.88
Cytokine and anticytokine therapy in dermatology. Expert Opin Biol Ther (2003) 0.87
Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol (2003) 0.87
In vivo distribution of carotenoids in different anatomical locations of human skin: comparative assessment with two different Raman spectroscopy methods. Exp Dermatol (2009) 0.87
Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol (2002) 0.87
Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis. J Invest Dermatol (2005) 0.87
Human papillomavirus and overexpression of P16INK4a in nonmelanoma skin cancer. Dermatol Surg (2004) 0.87
Follicular penetration: development of a method to block the follicles selectively against the penetration of topically applied substances. Skin Pharmacol Physiol (2006) 0.87
In vivo confocal scanning laser microscopy: comparison of the reflectance and fluorescence mode by imaging human skin. J Biomed Opt (2006) 0.87
Short German guidelines: cutaneous lymphomas. J Dtsch Dermatol Ges (2008) 0.87
Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women? Dermatology (2007) 0.87
Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study. Arch Dermatol (2004) 0.87
Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol (2006) 0.87
Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J Biomed Opt (2009) 0.86
Comparison of blood flow to the cutaneous temperature and redness after topical application of benzyl nicotinate. J Biomed Opt (2006) 0.86
Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. J Invest Dermatol (2012) 0.86
Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission x-ray microscopy. J Biomed Opt (2009) 0.86
Coordinated expression of clustered cancer/testis genes encoded in a large inverted repeat DNA structure. Gene (2008) 0.86
Proteome serological determination of tumor-associated antigens in melanoma. PLoS One (2009) 0.86
Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction. Leuk Lymphoma (2006) 0.85
Fine needle aspiration cytology of palpable and nonpalpable lymph nodes to detect metastatic melanoma. J Natl Cancer Inst (2011) 0.85
Cutaneous lycopene and beta-carotene levels measured by resonance Raman spectroscopy: high reliability and sensitivity to oral lactolycopene deprivation and supplementation. Eur J Pharm Biopharm (2009) 0.85
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients. Int J Cancer (2004) 0.85
Verrucae in a multicolored decorative tattoo. J Am Acad Dermatol (2004) 0.85